Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
juming jiangzhi tablets
- Development stage
- Unknown
- Lead developer
- Chongqing Sainuo Biological Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Juming Jiangzhi Tablets (Juming Jiangzhi Pian) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Chongqing Sainuo Biological Pharmaceutical for the treatment of hyperlipidemia. The product is designed to lower serum cholesterol and triglycerides by regulating lipid metabolism and inhibiting the absorption of exogenous lipids. Its primary herbal constituents typically include *Semen Cassiae* (Jumingzi), *Fructus Crataegi* (Shanzha), and *Radix Salviae Miltiorrhizae* (Danshen), which contain bioactive compounds such as anthraquinones and flavonoids known for their lipid-lowering properties. The drug is approved in China as a pharmaceutical product and is administered orally in tablet form.
- Brand names
- 决明降脂片Juming Jiangzhi Tablets
- Other names
- Juming Jiangzhi Pian
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Beyond the preview
Go deeper on juming jiangzhi tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on juming jiangzhi tablets.